Cargando…
The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2
A rare cause of megaloblastic anemia (MA) is thiamine-responsive megaloblastic anemia (TRMA), a genetic disorder caused by mutations in SLC19A2 (encoding THTR1), a thiamine transporter. The study objectives were to (1) functionally characterize selected TRMA-associated SLC19A2 variants and (2) deter...
Autores principales: | Enogieru, Osatohanmwen J., Koleske, Megan L., Vora, Bianca, Ngo, Huy, Yee, Sook Wah, Chatad, Derrick, Sirota, Marina, Giacomini, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921063/ https://www.ncbi.nlm.nih.gov/pubmed/33649974 http://dx.doi.org/10.1208/s12248-021-00562-4 |
Ejemplares similares
-
Drugs in COVID‐19 Clinical Trials: Predicting Transporter‐Mediated Drug‐Drug Interactions Using In Vitro Assays and Real‐World Data
por: Yee, Sook Wah, et al.
Publicado: (2021) -
Drug–nutrient interactions: discovering prescription drug inhibitors of the thiamine transporter ThTR-2 (SLC19A3)
por: Vora, Bianca, et al.
Publicado: (2020) -
Neural production of kynurenic acid in Caenorhabditis elegans requires the AAT-1 transporter
por: Lin, Lin, et al.
Publicado: (2020) -
The Impacts of Slc19a3 Deletion and Intestinal SLC19A3 Insertion on Thiamine Distribution and Brain Metabolism in the Mouse
por: Wen, Anita, et al.
Publicado: (2023) -
The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomics
por: Yee, Sook Wah, et al.
Publicado: (2023)